Expectation Setting for your Patient Advocacy Group (PAG)-Industry Partnership | PALADIN Members

Expectation Setting for your Patient Advocacy Group (PAG)-Industry Partnership Expectation Setting for your Patient Advocacy Group (PAG)-Industry Partnership Are you a Patient Advocacy Group (PAG) forming a new partnership with a pharmaceutical company or biotech? Are you a sponsor initiating a collaboration with a Patient Advocacy Group (PAG) and looking Read more…

A Collaboration Between PAG/Industry on Target Product Profile | PALADIN Members

A Collaboration Between PAG/Industry On Target Product Profile (TPP) A Collaboration Between PAG/Industry On Target Product Profile (TPP) PALADIN’s Interactive Guide to help the pharmaceutical industry and patient advocacy groups (PAGs) collaborate on the Target Product Profile (TPP), a critical planning tool used by industry to facilitate communication with the Read more…

Principles on Contracting Between Patient Advocates and Pharmaceutical Companies

Principles on Contracting Between Patient Advocates and Pharmaceutical Companies Principles on Contracting Between Patient Advocates and Pharmaceutical Companies | The National Health Council A set of rationale, examples, and guiding principles for legal agreements between pharmaceutical companies and patients from the National Health Council. View Here

Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit

Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit | Neighborhood Health Care and Altura This toolkit is a supplement to the white paper examining Read more…

About TransCelerate

About TransCelerate About TransCelerate | TransCelerate TransCelerate BioPharma Inc. is a non-profit organization with a mission to collaborate across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high-quality delivery of new medicines. View Here

Institutional Review Board Written Procedures: Guidance for Institutions and IRBs

Institutional Review Board Written Procedures: Guidance for Institutions and IRBs Institutional Review Board Written Procedures: Guidance for Institutions and IRBs | OHRP A guidance from the Department of Health and Human Services (HHS’s) Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) on procedures for IRB Read more…

Trust Builder: Supporting Patient Conversations About Mistrust Beliefs in Clinical Trials Printable Tool

Trust Builder: Supporting Patient Conversations About Mistrust Beliefs in Clinical Trials Printable Tool Trust Builder: Supporting Patient Conversations About Mistrust Beliefs in Clinical Trials Printable Tool | AAN and Sanofi CT staff or sponsors to build relationships with PAGs groups; information to life science to better to understand patients and Read more…

Conversation Starter to Support Patients/HCPS Dialogue: What Do Patients Frequently Ask About Clinical Studies?

Conversation Starter to Support Patients/HCPS Dialogue: What Do Patients Frequently Ask About Clinical Studies? Conversation Starter to Support Patients/HCPS Dialogue: What Do Patients Frequently Ask About Clinical Studies? | | AAN and Sanofi Tool from AAN and Sanofi for healthcare professionals to initiate discussions about clinical trials with patients before Read more…